A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

NCT06659770 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: Zevorcabtagene Autoleucel

Sponsor

CARsgen Therapeutics Co., Ltd.